Company Quick10K Filing
FactSet
10-Q 2021-02-28 Filed 2021-04-05
10-Q 2020-11-30 Filed 2021-01-06
10-K 2020-08-31 Filed 2020-10-29
10-Q 2020-05-31 Filed 2020-07-09
10-Q 2020-02-29 Filed 2020-04-09
10-Q 2019-11-30 Filed 2020-01-09
10-K 2019-08-31 Filed 2019-10-30
10-Q 2019-05-31 Filed 2019-07-10
10-Q 2019-02-28 Filed 2019-04-09
10-Q 2018-11-30 Filed 2019-01-09
10-K 2018-08-31 Filed 2018-10-30
10-Q 2018-05-31 Filed 2018-07-10
10-Q 2018-02-28 Filed 2018-04-09
10-Q 2017-11-30 Filed 2018-01-09
10-K 2017-08-31 Filed 2017-10-30
10-Q 2017-05-31 Filed 2017-07-10
10-Q 2017-02-28 Filed 2017-04-10
10-Q 2016-11-30 Filed 2017-01-09
10-K 2016-08-31 Filed 2016-10-31
10-Q 2016-05-31 Filed 2016-07-11
10-Q 2016-02-29 Filed 2016-04-11
10-Q 2015-11-30 Filed 2016-01-11
10-K 2015-08-31 Filed 2015-11-02
10-Q 2015-05-31 Filed 2015-07-10
10-Q 2015-02-28 Filed 2015-04-09
10-Q 2014-11-30 Filed 2015-01-09
10-K 2014-08-31 Filed 2014-10-30
10-Q 2014-05-31 Filed 2014-07-10
10-Q 2014-02-28 Filed 2014-04-09
10-Q 2013-11-30 Filed 2014-01-09
10-K 2013-08-31 Filed 2013-10-30
10-Q 2013-02-28 Filed 2013-04-09
10-Q 2012-11-30 Filed 2013-01-09
10-K 2012-08-31 Filed 2012-10-30
10-Q 2012-05-31 Filed 2012-07-10
10-Q 2012-02-29 Filed 2012-04-09
10-Q 2011-11-30 Filed 2012-01-09
10-K 2011-08-31 Filed 2011-10-31
10-Q 2011-05-31 Filed 2011-07-11
10-Q 2011-02-28 Filed 2011-04-06
10-Q 2010-11-30 Filed 2011-01-10
10-K 2010-08-31 Filed 2010-10-29
10-Q 2010-05-31 Filed 2010-07-09
10-Q 2010-02-28 Filed 2010-04-09
10-Q 2009-11-30 Filed 2010-01-08
8-K 2020-12-21 Earnings, Exhibits
8-K 2020-12-17 Shareholder Vote
8-K 2020-09-24
8-K 2020-09-21
8-K 2020-06-23
8-K 2020-06-07
8-K 2020-03-26
8-K 2020-02-29
8-K 2019-12-19
8-K 2019-12-19
8-K 2019-09-26
8-K 2019-07-11
8-K 2019-06-25
8-K 2019-05-28
8-K 2019-04-16
8-K 2019-03-29
8-K 2019-03-26
8-K 2019-02-08
8-K 2018-12-18
8-K 2018-12-18
8-K 2018-11-30
8-K 2018-09-25
8-K 2018-08-31
8-K 2018-07-27
8-K 2018-07-05
8-K 2018-06-26
8-K 2018-05-08
8-K 2018-04-17
8-K 2018-03-27
8-K 2017-12-31

FactSet Financials

FDS Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
ENETI INC. (NETI)
024 Pharma (EEIG)
Vivus (VVUS) 41 77% -17.5 -11% 226 289 73 56 -25 -14 243
Clovis Oncology (CLVS) 219 0% -0.0 -56% 717 804 134 0 -400 -394 18
Cementos Pacasmayo Saa (CPAC) 4,145 0% 2,863 1,412 0 0 0 0 4,145
11 Good Energy (ELVN)
Exantas Capital (XAN)
1347 Capital Corp (TFSC)
Bancorp of New Jersey (BKJ) 123 1.0 0% 962 869 0 0 3 15 14
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
1st United Bancorp (FUBC)
2-Track Global (TTG)
ENTERGY ARKANSAS, LLC (EAI)
21st Century Oncology Holdings (RTSX)
24Holdings (TWFH)
30DC (TDCH)
3D Pioneer Systems (DPSM)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2010-11-302011-02-282011-05-312011-08-312011-11-302012-02-292012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-02-282019-05-31
Cash20220320918219418522918921115124319717489119116115122158159180175187228173155162195222234213209170218324
Accounts Receivable647168756571677479866973769886908810092959910610598110131147148145165145157160176153
Inventory
PP&E16917017617418118618319019019218919219019219720219720320621323123324125326426997294999794346102105105
Assets6596836856576646646956947126707356906716546606636467107287371,0181,0221,0391,0191,0461,0621,3581,4131,4311,4721,4071,4191,3661,4651,512
Accounts Payable
Long-Term Debt353535300300300300365365575575575575575575575575574
Liabilities117125130142127120134142125123132148125136144152145180196205460481495502549569830854812860872894825865857
Stockholders' Equity543558554515536544560552587547603542547518515511502529532532558541544517497493528560618612535526541600654
Income Statement ($MM)2010-11-302011-02-282011-05-312011-08-312011-11-302012-02-292012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-02-282019-05-31
Revenue173178184192196199202208211213215219223227232239243248255262271282288287288294312327329335340346352355365
Cost of Revenue5760626567686972747677808387919398100101108115124125124127132146161162163165169167165164
Gross Profit117117121126130132133135137137138139140140141146145148154154156158163163161163166165168172175176185190201
R&D
SG&A5759606763656565668166696565686765686869687374757071788379778288848183
Tax1813191821212123221219202323222425202424271722562323202016391515122021
Net Income42454341464748495045535152525255566261626068671446767656070587569848592
Cash Flow ($MM)2010-11-302011-02-282011-05-312011-08-312011-11-302012-02-292012-05-312012-08-312012-11-302013-02-282013-05-312013-08-312013-11-302014-02-282014-05-312014-08-312014-11-302015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-312018-08-312018-11-302019-02-282019-05-31
Cash Operating225065705544765751469776584195717150102847193977051779261931261064699160
Cash Investing-8-7-7-7-21-5-6-27-6-4-5-6-21-35-4-11-10-37-7-11-278-12-9141-81-14-239-5-7-6-30-7-12-10
Cash Financing-9-46-54-90-16-49-20-73-25-1002-116-63-91-62-60-57-1-58-72232-81-81-161-18-81150-31-77-133-79-75-41-40